TOKYO -- Japan will shorten the examination period for an artificial-intelligence-powered diagnostic imaging software and other med-tech to be approved for commercial use, Nikkei has learned.
New system means tech can be in commercial use within a year of development

AI software, or 'software as a medical device', includes tech that can automatically detect suspicious lesions or shadows from X-ray images and endoscopic images of the large intestine, for example. (Photo courtesy of Fujifilm)
TOKYO -- Japan will shorten the examination period for an artificial-intelligence-powered diagnostic imaging software and other med-tech to be approved for commercial use, Nikkei has learned.